The Value of Contrast-Enhanced Magnetic Resonance Imaging Enhancement in the Differential Diagnosis of Hepatocellular Carcinoma and Combined Hepatocellular Cholangiocarinoma

Figure 2

cHCC-CC presenting in a 42-year-old man. (a)-(b) multiple lesions (red arrow) and nonsmooth margin (white arrow) on T2WI; (c) the arterial phase shows obvious peritumoral enhancement (yellow arrow); and (d) without capsule shows in enhanced portal phase images.

(a)

(b)

(c)

(d)